Bank of New York Mellon’s EMULEX CORP ELX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-342,016
Closed -$2.73M 4397
2015
Q1
$2.73M Sell
342,016
-204
-0.1% -$1.43K ﹤0.01% 2656
2014
Q4
$1.94M Sell
342,220
-56,777
-14% -$306K ﹤0.01% 2900
2014
Q3
$1.97M Sell
398,997
-165,404
-29% -$895K ﹤0.01% 2893
2014
Q2
$3.22M Buy
564,401
+43,666
+8% +$260K ﹤0.01% 2616
2014
Q1
$3.85M Sell
520,735
-15,974
-3% -$117K ﹤0.01% 2447
2013
Q4
$3.84M Sell
536,709
-152,207
-22% -$1.13M ﹤0.01% 2461
2013
Q3
$5.35M Buy
688,916
+13,220
+2% +$103K ﹤0.01% 2203
2013
Q2
$4.41M Buy
+675,696
New +$4.25M ﹤0.01% 2260

Bank of New York Mellon's ELX Position: Q2 2015 in Review

Bank of New York Mellon sold out of EMULEX CORP (ELX) in Q2 2015, closing a stake of 342,016 shares — an estimated $2.73M sold.

Bank of New York Mellon first reported a position in ELX in Q2 2013 and held it in 8 quarters. The position peaked at $5.35M in Q3 2013. 0 funds tracked by Wall St. Rank hold ELX as of Q2 2015.

  • Bank of New York Mellon reported no remaining EMULEX CORP position as of Q2 2015 after selling out during the quarter.
  • Bank of New York Mellon sold 342,016 EMULEX CORP shares in Q2 2015, an estimated $2.73M.
  • Bank of New York Mellon first reported a position in EMULEX CORP in Q2 2013 and held it in 8 quarters.
  • Bank of New York Mellon's EMULEX CORP position peaked at $5.35M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held EMULEX CORP as of Q2 2015.

Based on Bank of New York Mellon's 13F filing for Q2 2015, filed 6 Aug 2015.